Company
Kyverna Therapeutics (San Diego)
Overview
Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing clinical trials across multiple autoimmune conditions.
Company
Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing clinical trials across multiple autoimmune conditions.